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Repeat coronary artery bypass operations were per-
formed on 112 patients at a university hospital between
1971 and 1981. When compared with patients who did
poorly after a first operation but did not have repeat
surgery, patients undergoing repeat surgery tended to
be younger, to have a higher smoking rate and to have
fewer prior myocardial infarctions, fewer diseased ves-
sels and fewer lesions in distal vessels. At least 1 graft
wasoccluded in 83% of patients undergoing reoperation,
and a mean of 1.7 grafts were placed at reoperation.
The operative mortality rate was 4%, with a follow-up
mortality rate of 6% at a mean of 3.8 years. After re-
operation, patients initially showed improvement to a
mean specific activity scale class of 1.6, compared with
Repeat coronary artery bypass grafting has become a fre-
quently used therapeutic option in patients with coronary
artery disease. More than 2,000 reoperations have been
reported since 1977 (1-15) and, at hospitals reporting re-
operation data, about 2.5% of all coronary artery bypass
operations in the period from 1977 to 1982 have been re-
operations (2-5,7,9-11,14,15). The operative mortality rate
for reoperations in pooled data has been only 3.2%
(1-5,7-9,11,13-15), and about 60 to 90% of patients
respond to reoperation with symptomatic improvement
(1-6,8,9,12).
In 1977, data from the first 26 reoperations performed
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2.4 before the first operation and 2.7 before the second
operation.
The principal correlate of a better long-term symp-
tomatic responsecompared with that in the period before
the first operation was a lower serum cholesterol level,
whereas the principal correlate of a better symptomatic
response compared with that in the period just before
the reoperation was the left ventricular ejection fraction.
As recurrent symptoms after a first coronary artery op-
eration becomemore prevalent, consideration of the se-
lection factors and prognostic correlates of reoperation
will become increasingly important.
(J Am Coil CardioI1986;8:274-9)
at our hospital suggested that patients with hyperlipidemia
might be more likely to require reoperation (16). The aims
of the present study were to determine how patients undergo-
ing reoperation over a full decade differed from a group of
patients who had only one coronary artery operation during
the same time period, to determine the clinical response to
coronary artery reoperation at our hospital and to determine
whether any clinical or angiographic criteria were correlated
with the long-term symptomatic response to coronary artery
reoperation.
Methods
Study patients. We reviewed the Harvard-Brigham and
Women's Hospital Coronary Artery Disease Databank (17),
which is patterned after the Duke University Medical Center
Databank (18), and the operating room logs at our hospital
for the period from June 1971 to September 1981 to identify
112 patients who underwent coronary artery reoperation.
For the purposes of this study, a first operation was defined
as the first placement of a saphenous vein graft or an internal
mammary artery anastomosis to a coronary vessel; opera-
tions limited to an internal mammary artery myocardial im-
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plant were not included in this definition. For each patient ,
we gathered detailed clinical, angiographic , hemodynamic
and surgical data using a standard protocol (17, 18) for both
the initial and repeat operations. However, although patients
in our regular data bank are entered prospectively at the
time of cardiac catheterization at our hospital , in many pa-
tients undergoing reoperation catheterization was performed
elsewhere.
Clinical data. In this analysis, we concentrated on fac-
tors that might correlate with the performance and long-
term outcome of a coronary artery reoperation, including
age, sex, coronary risk factors , the clinical severity of the
coronary disease, the extent and distribution of coronary
disease at catheterization and left ventricular function. In
addition, we gathered data on the interval between the first
and second operations and on any interval progression in
the coronary artery disease. The left ventricular contraction
pattern was categorized as normal , mildly abnormal (when
only one myocardial segment was abnormal) or diffusely
abnormal. Left ventricular ejection fraction was recorded
when available, but it was not routinely measured in our
hospital in the early 1970s or in some of our referring hos-
pitals until later. Furthermore, in some patients with re-
operation, left ventricular angiography was not repeated at
the catheterization before the second operation.
Follow-up. Follow-up was performed by telephone in-
terview and by review of all pertinent medical records. The
follow-up interview included information on current symp-
toms, medications and activity levels. Patients were asked
a series of questions to evaluate their functional status ac-
cording to the criteria of the New York Heart Association
(19,20) and the specific activity scale (21,22) at five points
in time: just before their first bypass operation, their best
status after the first operation, their status just before their
second bypass operation, their best status after the second
operation and their current status.
The specific activity scale is a brief set of questions that
elicits the activities a person can perform and, by knowing
the approximate metabolic equivalents of oxygen consump-
tion that are required for the person 's most strenuous activ-
ity, categorizes the person in class I if the activity requires
7 or more metabolic equivalents , class II if the activity
requires 5 or more but less than 7 metabolic equivalents,
class III if the activity requires 2 or more but less than 5
metabolic equivalents and class IV if the activity requires
less than 2 metabolic equivalents. In prior testing , the spe-
cific activity scale was more reproducible (2 1), more valid
(21) and less subject to bias as the patient's disease pro-
gressed (22) when compared with the New York Heart As-
sociation criteria.
Surgical mortality data were available for all 112 pa-
tients undergoing reoperation. Some symptomatic follow-
up data were available for 90 of these patients; 80 had full
symptomatic follow-up data, using the specific activity scale,
available before and after both coronary artery bypass graft
procedures. For another eight patients, full specific activity
scale data could not be obtained retrospectively but full data
were available using the New York Heart Association scale.
Although classifications using the two systems are not iden-
tical , for the purposes of this study we pooled specific ac-
tivity scale data on the 80 patients with the New York Heart
Association data on the additional 8 patients .
Long-term improvement compared with the status before
the first operation was defined in patients who, since the
period before the first operation , I) had not died or had an
interval myocardial infarction , and 2) were improved by one
or more specific activity scale classes or were in class I.
Long-term improvement compared with the status before
reoperation used the same criteria but contrasted the present
status to the status just before reoperation. Of the 112 pa-
tients undergoing reoperation, sufficient data were available
to classify the presence or absence of long-term improve-
ment by these two definitions in 102 (91%) and 103 (92%)
patients, respectively.
Coronary angiographic analysis. In our analyses , na-
tive coronary artery or graft stenoses of 50% or more of the
luminal diameter were defined as significant. Progression
of coronary artery disease was defined as an increase in
stenosis of 25% or more of the luminal diameter from the
first to the second catheterization , or the appearance at the
second catheterization of a new, previously unreported 50%
or greater stenosis . Distal coronary artery stenoses were
defined as 50% or greater diameter stenoses of the distal
left anterior descending artery , distal left circumflex artery,
distal right coronary artery beyond the posterior descending
branch, third left anterior descending diagonal branch, third
obtuse marginal branch or the posterolateral left ventricular
branches of either the left or the right coronary system.
Control patients. To determine how patients undergo-
ing reoperation compared with patients who had only one
operation, we used our coronary artery disease data bank
to identify 237 patients who were catheterized between Jan-
uary 1, 1977 and December 31, 1980, who then underwent
a first coronary artery bypass operation without concomitant
valve replacement or aneurysm surgery within 6 months of
the catheterization, and on whom yearly symptomatic data
had been obtained . Because the more reproducible and valid
specific activity scale (21,22) was not available during the
early years of the databank, the symptomatic statusof con-
trol patients, who underwent one coronary artery bypass
operation but did not undergo repeat surgery , was deter-
mined using the New York Heart Association criteria (19,20).
We classified patients who had only one operation into two
groups: those who were alive and had sustained , substantial,
symptomatic improvement versus those who did not. For
the purposes of this study, sustained substantial sympto-
matic improvement was defined as I) improvement by two
New York Heart Association classes compared with status
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before the bypas s graft procedure, or being in class I, and
2) being alive without havin g had an interval myocardial
infarction.
Statistical methods. Univariate comparisons of cate-
gor ic data were performed using the chi-square statistic with
the appropriate degrees of freedom. Univariate comparisons
of continuous data were performed using a Student's t test
when two groups were being compared and using analysis
of variance (23) when more than two groups were being
comp ared . If the overall analysis of variance was significant,
indiv idual t tests were performed to compare each of the
various pairs of groups. The correlation of the interval be-
tween the first and second operations with the patient's age
was tested using a nonparametric Kendall correlation coef-
ficient (23). Multivariate logistic regression analysis (23)
was used to assess the independent significance of possible
correlates of management selection or prognosis after con-
troll ing for other factors. Onl y facto rs kno wn at the time of
the first operation were considered in the analysis of cor-
relates of improvement since that time , and all factor s known
at the time of reoperation were con sidered in the analysis
of correlates of outcome since just before the reoperation .
Results
Comparison of reoperation patients with patients hav-
ing only one operation (Table 1). Between 1971 and 1981,
there were 2 ,447 patients who had coronary artery bypas s
graft ing at our hospital , including 112 patients (4 .6%) who
had a second coronary arte ry bypass operation . In compar-
ison with patients who did either well or poorl y after one
Table I. Findings at Time of First Coronary Artery Bypass Grafting
operation and did not have a second operation , the 112
patient s undergoing a repeat operation tended to be younger,
to have a higher serum cholesterol level , fewer prior myo-
cardial infarctions , fewer diseased vessels and less distal
vessel disease . After controlling for age and sex, patients
undergoing reoperation had less distal vessel disease
(p < 0.01), and tended to have fewer diseased vessels (p
== 0 .06). After controlling for age, sex and number of
diseased vessels, patients undergoing reoperation had a higher
cholesterol level (p < 0.05).
Reoperation results. The mean interval between the first
and second operation was 3 years (range < 1 month to 10.6
years) . The interval between operations was shorter in pa-
tient s who were older at the time of their first operation
(p < 0 .01).
Patients with reoperation received a mean of 2.0 grafts
at their first operation. At catheterization before the second
operation , 34% of the patient s had all grafts occluded, 49 %
had some but not all grafts occluded and 17% of pat ients
had no occluded grafts. In the group with reoperation , 82%
had progres sion of native disease , including 63 % who had
progression in a vessel that had been grafted at the first
operation . At reoperation , a mean of 1.7 grafts were placed.
The rate of operative mortality, defined as death within 31
days of reoperation , was 4%, with a subsequent additional
mortality rate of 6% during a mean of 3.8 years of follow-
up.
Bef ore the first bypass operation, patients with reoper-
ation had a mean funct ional classification of 2.4. Afte r the
first operation , these patients showed improvement to a mean
functional class of 1.6 . Before reoperation, their functional
Patients Having Only One Operation
Patients Who Did Patients Who Did
Patient s With Well After First Poorly After First
Reoperation Operation Operation Analysis of
(n = 112) (n = 171) (n = 66) Variance
Cli nical data
Age (yr) 50 ::!:: 10 55 ::!:: 9 56 ::!:: 10 < 0.000 1*
Sex (% male) 80 85 77 NS
Mean serum cholesterol (mg/dl) 258 ::!:: 56 237 ::!:: 48 246 ::!:: 60 < 0. 05t
Diabetes (%) 14 13 18 NS
History of hypertension (%) 39 44 50 NS
Smoking (%) 59 43 44 <0.05"
Obesity (%) 17 19 20 NS
Mean number of prior MIs 0.7 0.7 1.1 < 0.05t
Coronary angiog raphic data
Number of diseased vesse ls 2.3 2.6 2.5 < 0. 05*
Left main disease (%) 13 20 24 NS
Distal lesions (%) 24 42 45 < 0 .005*
*By I test, patients with reoperation were significantly different from both I) patients who did well after a first operation, and 2) patients who did
poorly but did not have a reoperation . t By I test , patients with reoperation were significantly different from patients who did well after a first operation .
t By I test , both I) patients with reoperation , and 2) patients who did well after a first operation were significantly different from patients who did poorly
but did not have a second operation. MI = myocardial infarction; n = number of patients; NS = not significant.





state deteriorated to a mean class of 2.7, but after reoper-
ation, they attained a mean best class of 1.6. Initially, 78%
of patients with reoperation were in class I or showed im-
provement by at least one class compared with their status
before the first operation, and 27% showed improvement
by two or more classes. At a mean follow-up time of 4 ±
3 years (range up to 10 years) after reoperation, the mean
functional class was 1.9.
Correlates of symptomatic outcome. Long-term im-
provement compared with status before the first operation
(mean 7 ± 3 years of follow-up, range up to 14 years) was
achieved in 54% of the patients undergoing reoperation.
After controlling for variable follow-up times, this improve-
ment was significantly more likely in patients with a lower
serum cholesterol level at the time of the first operation
(p < 0.05) and in patients over 50 years of age at the time
of the first operation (p < 0.05). Other factors measured at
the time of the first operation, including hypertension, di-
abetes, smoking, obesity, prior myocardial infarctions, left
main coronary artery disease, distal vessel disease, the num-
ber of diseased vessels, the number of grafts placed, the
left ventricular contraction pattern, the left ventricular ejec-
tion fraction and the left ventricular end-diastolic pressure
were not correlated with this definition of improvement. In
the multivariate analysis that controlled for variable follow-
up times, the only significant correlate was the serum cho-
lesterollevel, with long-term improvement compared with
status before the first operation noted in only 32% of patients
with a cholesterol level above 260 mg/dl versus 60% of
patients with a lower cholesterol level.
Long-term improvement compared with status before re-
operation (mean 4 ± 3 years of follow-up, range up to 10
years) was achieved in 52% of patients. After controlling
for variable follow-up times, this improvement was signif-
icantly correlated with a higher ejection fraction at the time
of reoperation (p < 0.01) and with age over 50 years at the
time of reoperation (p < 0.05). Other factors measured at
the time of reoperation, including cholesterol level, pro-
gression of disease since the first operation and interval
between the first and second operations, were not significant
correlates. In the multivariate analysis, only left ventricular
ejection fraction at the time of reoperation correlated with
this definition of improvement. Mean ejection fraction was
64% in patients with improvement versus 57% in patients
without improvement, but this result must be considered in
light of the fact that the ejection fraction just before reop-
eration had been measured in only 71% of the patients in
this analysis.
Discussion
Although the clinical response to coronary artery bypass
grafting is generally good, the patency rate of saphenous
vein grafts declines to a range of between 38 and 68% at
10 years after surgery (24). Given the large number of
bypass operations performed annually in this country, it is
no surprise that reoperations are becoming increasingly
common.
Our review of patients having a second coronary oper-
ation at our hospital between 1971 and 1981 encompassed
a period of time during which major technical advances
occurred in cardiac surgery and bypass grafting, and the
mortality of coronary artery reoperations may now be lower.
For example, Loop et al. (12) reported that operative mor-
tality for reoperations declined from 5% during the period
1969 to 1976 to 2% during the period 1981 to 1982. How-
ever, our review (25) of more than 2,000 patients who
underwent a first coronary artery bypass grafting without
concomitant valve replacement or aneurysmectomy between
January 1970 and December 1980 showed that, after con-
trolling for clinical severity, long-term mortality did not
differ in the later years compared with the earlier years.
Comparison with prior studies. In many ways, our
patients with reoperation were reasonably similar to those
reported in prior studies. Our patients had 1.7 grafts placed
at reoperation, which is similar to a range of 1.4 to 2.3
reported by others (1,3,4-7). Our 83% rate of occlusion of
one or more grafts from the first operation was very similar
to that in other studies, which have reported a range of 59
to 89% (1,2,4,6-11). Also, our operative mortality was not
substantially different from the 3.3% mortality rate in pooled
data on 2,030 patients (1-5,7-9,11-14). Finally, our pa-
tients with reoperation, some of whom had their initial op-
eration elsewhere, represented 4.6% of the bypass proce-
dures at our hospital during the period between 1971 and
1981, which was slightly higher than the 2.5% reoperation
rate reported between 1977 and 1982 at 10 other institutions
(2-5,7,9-11,14,15).
Comparison ofour patients undergoing reoperation with
patients who did not undergo reoperation despite a poor
symptomatic response to the first operation revealed that
patients with reoperation tended to be younger, to be more
likely to smoke and to have fewer prior myocardial infarc-
tions, fewer diseased vessels and fewer distal lesions. These
findings indicate that, in general, patients undergoing re-
operation were believed to have less severe disease and a
better chance for a good postoperative outcome than were
patients who did not have a repeat operation, despite having
a poor symptomatic response to the initial surgery. How-
ever, their younger age, higher smoking rate and higher
serum cholesterol level compared with patients who did well
after a first operation suggest that our patients with a second
operation may also have had disease that would be more
rapidly progressive in the future. Barboriak et al. (10) also
reported that patients undergoing reoperation were younger
and were more likely to have an elevated serum cholesterol
level than were patients who did not undergo reoperation,
but they did not distinguish between patients who did not
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undergo reoperation because they continued to do well ver-
sus those who did not undergo reoperation despite recurrent
symptoms.
Correlates of symptomatic outcome. Reported corre-
lates of survival after a second operation have been the
extent of the coronary artery disease (1,12) and the status
of the left ventricle (12). Data on the symptomatic response
to reoperation suggest that a majority of patients are in
improved condition postoperatively. Although the defini-
tions have varied among studies, initial improvement rates
have been as high as 88% (2), with 60 to 80% of survivors
reported as being improved at intervals ranging from about
18 to 40 months after reoperation (1,3-6,8,9,13). An im-
portant contribution of our study was the use of the specific
activity scale (21,22) to provide a more precise definition
of improvement.
In our analysis, the principal correlate of long-term symp-
tomatic improvement since before the first operation was a
lower serum cholesterol level. Campeau et al. (26) also
found that serum lipoprotein levels were the principal cor-
relates of the development of graft atherosclerosis and of
the progression of native coronary disease in patients studied
10 years after bypass surgery. Therefore, it is not surprising
that in the present study, the cholesterol level correlated
with the long-term symptomatic course.
In contrast to the analysis based on improvement since
the period before the first operation, improvement at a mean
of 4 ± 3 years after reoperation was principally correlated
with the left ventricular ejection fraction. Our findings are
consistent with other data on the importance of left ven-
tricular function after initial and repeat coronary operations
(12,25). In our series, left ventricular function appeared to
be the strongest correlate of medium-term outcome after the
reoperation, whereas the cholesterol level, as a major de-
terminant of progressive atherosclerosis (26), exerted its
effects only over the longer term, that is, the 7 ± 3 years
(range up to 14 years) since the period before the first op-
eration.
The early return of symptoms after coronary artery sur-
gery is commonly due to graft failure, whereas symptoms
appearing later are more likely to be caused by atheroscle-
rosis either in the graft or in the native vessels (24,26). We
found no correlation between the long-term outcome after
reoperation and the interval from the first to the second
operation.
Conclusions. As the recurrence of symptoms after coro-
nary artery surgery becomes a growing problem, an in-
creasing number of patients will be considered as candidates
for repeat coronary artery bypass grafting. Our data suggest
that patients with more aggressive atherosclerotic disease,
as evidenced by younger age and especially by a higher
cholesterol level, are at higher risk of having an unsatis-
factory long-term outcome and that patients with a lower
ejection fraction are less likely to have improvement after
reoperation. The prospective identification of these patients
should allow for better patient selection as well as for careful
consideration of percutaneous transluminal angioplasty of
the graft or of native coronary disease (27,28).
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